JaredSpitzMD
@JSpitz_MD
Osler IM resident. Cornell Cardio Fellow. Inova Cardiology. CV prevention and lipids.
ID:1052605876287225856
17-10-2018 17:02:52
412 Tweets
187 Followers
244 Following
Out in Nature Cardiovascular Research, led by Arya Aminorroaya CarDS Lab, is an #ML tool to make Lp(a) testing more efficient - ARISE
⬆️Lp(a) is an atherosclerotic risk marker w therapies on the horizon, but testing is ⬇️⬇️
ARISE can reduce number-needed-to-test ~50%
🧵👇🏽
rdcu.be/dHqop
Nice randomized trial just published: likely that combining early TRE with exercise provides additive, if not synergistic, benefits
Todd Neale PLOS ONE TCTMD Pam R. Taub, MD❤️💃🏻 Satchin Panda Emily Manoogian ASPC Heather M. Johnson, MD, MMM, FAHA, FACC, FASPC
journals.plos.org/plosone/articl…
tctmd.com/news/time-rest…
Jaideep The Osler Medical Residency Abhi Gami Johns Hopkins Ciccarone Center Johns Hopkins Cardiology Gupta-Klinsky India Institute Michael J. Blaha Khurram Nasir Matthew Budoff MD Suvasini Lakshmanan Once CAC > 100 , can we call it “secondary” prevention. Even today many cardiologist not aware to treat existing plaque / CAD aggressively. Why wait for a possible fatal event?
Given that being #SouthAsian is a “risk-enhancer” per ACC/AHA guidelines, we need more tools that “enhance” risk assessment.
#CACtesting may be a good tool👇🏾
#SouthAsian CVD #CVPrev
Take your kid to conferences. Give them all the iPad time, treats, and pool time they desire. Skip some sessions. Allow the giggles during the board meeting. Show it can be done, especially if you’re in leadership.
Let’s put the humanity back into our work spaces. Academic Mom, PhD
Excited to report that Shashank Desai performed the first Inova Schar Heart and Vascular implant of the preCARDIA balloon occlusion device to intermittently occlude the SVC, as part of VENUS HF, investigating feasibility/safety of this therapy for diuretic resistant, acute heart failure.
Proud of Lindsey Cilia, recipient of SCAI Now 30 in Their 30s Award, recognizing early-career interventional cardiologists on their way to being future leaders in the field.
Christopher O'Connor Ketan Trivedi
Delighted to see our European Society of Hypertension Working Group Position Statement led by Costas Thomopoulos published in J Hypertension & just in time for ESH Annual Meetings #ESH2024 Reinhold Kreutz
Management of hypertensive disorders in pregnancy #HDP : Position Statement of the ESH Working Group…
WORLD PULMONARY HYPERTENSION DAY IS MAY 5TH. HELP MAKE THE WORLD #PHAWARE BY SHARING INFO ABOUT #PULMONARYHYPERTENSION , A RARE, LIFE-THREATENING DISEASE THAT AFFECTS THE ARTERIES OF THE LUNGS AND CAN LEAD TO RIGHT HEART FAILURE. #WORLDPHDAY2023 PHAWARE.GLOBAL
🔴 Statin Selection for Primary Prevention (Active vs Passive): The CorCal Vanguard Trial
🔴Primary ASCVD Prevention: Optimally Active, Agile, and Accountable #editorial
#OpenAccess JACC Journals
✅jacc.org/doi/10.1016/j.…
✅jacc.org/doi/10.1016/j.…
#CardioEd #Cardiology
#KnowHoFH
In honor of #HoFHAwarenessDay , I’m pleased to share an article I co-authored with Christie Ballantyne, Allison Jamison, Sam Gidding and others👇🏻
It is Time to Screen for Homozygous Familial Hypercholesterolemia in the United States - Global Heart globalheartjournal.com/articles/10.53…
Today is homozygous familial hypercholesterolemia awareness day!This, and all genetic lipid disorders, are under recognized and under treated. Please check and refer to lipid experts as so many options now exist to treat! Family Heart Foundation National Lipid Association